pdufa.bio

Lifileucel

Page updated ·next FDA decision on the calendar ·Data as of Nov 5, 2026 5:03 AM ET

Lifileucel is an Iovance Biotherapeutics, Inc. program. Its next catalyst is a Readout in Apr 2027. Every date links its source.

IOVA catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Iovance Biotherapeutics, Inc. (IOVA). We track 3 catalyst events for this program: 2 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2026IOVAReadout · Apr 2027IOVAReadout · Nov 2027IOVA

Questions

When is Lifileucel's next FDA decision or readout?

The next tracked catalyst for Lifileucel is a Readout in Apr 2027.

What happened at Lifileucel's most recent FDA decision?

No FDA decision for Lifileucel is in our archive yet.

Who makes Lifileucel?

Iovance Biotherapeutics, Inc. (IOVA).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.